Dexela
3-D Breast Imaging
Dexela is developing accurate and sensitive 3-D breast imaging technology for the early detection of breast cancer, known as Tomosynthesis.
The early detection of breast cancer using screening mammography significantly reduces mortality. However, conventional mammography still has a significant rate of both false negatives and false positives, particularly in younger women. Dexela is developing innovative technology for 3D breast imaging, which promises to significantly reduce both false negatives and false positives, allowing the earlier detection of cancer while reducing the occurrence of callbacks. Dexela has developed the leading intellectual property position covering powerful methods to acquire, process and visualize data from 3D X-ray breast imaging. Dexela is playing a central role in this field through collaborative agreements with medical device manufacturers.
Download the award winning paper Medical Physics paper to learn more about the technology.
|
|